Effectiveness of Triclabendazole Against Liver Fluke Infections
Liver fluke infections are parasitic diseases caused primarily by Fasciola hepatica and Fasciola gigantica. These parasites infect the liver and bile ducts, leading to a condition known as Fascioliasis. The infection is typically acquired by consuming contaminated water or aquatic plants. Symptoms may include fever, abdominal pain, nausea, liver enlargement, and in chronic cases, biliary obstruction and inflammation.
Triclabendazole is considered the treatment of choice for fascioliasis due to its high efficacy against both immature and adult stages of liver flukes. Unlike many other anthelmintic drugs that mainly target adult worms, Triclabendazole is effective during the early migratory phase of infection, when larvae are moving through liver tissue. This unique property makes it particularly valuable in preventing complications and long-term liver damage.
The drug works by disrupting the parasite’s microtubule function and energy metabolism, leading to paralysis and death of the fluke. Clinical studies have demonstrated cure rates exceeding 80–90% after a single or double dose regimen, depending on the severity of infection. It is usually administered as a single oral dose of 10 mg/kg, sometimes repeated after 12–24 hours if necessary.
Triclabendazole is generally well tolerated. Mild side effects such as headache, abdominal discomfort, or nausea may occur, often related to the body’s reaction to dying parasites rather than the medication itself.
Overall, Triclabendazole remains a highly effective and reliable therapy for liver fluke infections, significantly reducing parasite burden and preventing serious hepatic complications when used appropriately under medical supervision.
Visit: https://www.medzsupplier.com/product/triclabendazole-250mg/
